{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:11:22Z","timestamp":1789456282776,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002975","name":"Sumitomo Dainippon Pharma Co. Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25293320"],"award-info":[{"award-number":["25293320"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K15662"],"award-info":[{"award-number":["16K15662"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K15617"],"award-info":[{"award-number":["17K15617"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iPS Cell Research Fund"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Reports"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.stemcr.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T10:43:51Z","timestamp":1541069031000},"page":"1106-1119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["An mTOR Signaling Modulator Suppressed Heterotopic Ossification of\u00a0Fibrodysplasia Ossificans Progressiva"],"prefix":"10.1016","volume":"11","author":[{"given":"Kyosuke","family":"Hino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Horigome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasue","family":"Okanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Komura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Toguchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ikeya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stemcr.2018.10.007_bib1","doi-asserted-by":"crossref","first-page":"E338","DOI":"10.1073\/pnas.1515397113","article-title":"Inhibition of Hif1alpha prevents both trauma-induced and genetic heterotopic ossification","volume":"113","author":"Agarwal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.stemcr.2018.10.007_bib2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/stem.2515","article-title":"Scleraxis-lineage cells contribute to ectopic bone formation in muscle and tendon","volume":"35","author":"Agarwal","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.stemcr.2018.10.007_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1247\/csf.25.195","article-title":"Differential expressions of BMP family genes during chondrogenic differentiation of mouse ATDC5 cells","volume":"25","author":"Akiyama","year":"2000","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.stemcr.2018.10.007_bib4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"Anastassiadis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stemcr.2018.10.007_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/gene.20180","article-title":"Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells","volume":"44","author":"Beard","year":"2006","journal-title":"Genesis"},{"key":"10.1016\/j.stemcr.2018.10.007_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1359\/jbmr.071030","article-title":"Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP)","volume":"23","author":"Billings","year":"2008","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.stemcr.2018.10.007_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bone.2017.08.023","article-title":"Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva (FOP)","volume":"109","author":"Brennan","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.stemcr.2018.10.007_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/er.2002-0023","article-title":"Bone morphogenetic proteins, their antagonists, and the skeleton","volume":"24","author":"Canalis","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.stemcr.2018.10.007_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1242\/dmm.023929","article-title":"High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva","volume":"9","author":"Cappato","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.stemcr.2018.10.007_bib10","doi-asserted-by":"crossref","first-page":"36990","DOI":"10.1074\/jbc.M112.365932","article-title":"Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva","volume":"287","author":"Chaikuad","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.stemcr.2018.10.007_bib11","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jbmr.2820","article-title":"Palovarotene inhibits heterotopic ossification and maintains limb mobility and growth in mice with the human acvr1(r206h) fibrodysplasia ossificans progressiva (fop) mutation","volume":"31","author":"Chakkalakal","year":"2016","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.stemcr.2018.10.007_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jbmr.3304","article-title":"Depletion of mast cells and macrophages impairs heterotopic ossification in an acvr1R206H mouse model of fibrodysplasia ossificans progressiva","volume":"33","author":"Convente","year":"2017","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.stemcr.2018.10.007_bib13","doi-asserted-by":"crossref","first-page":"366ra163","DOI":"10.1126\/scitranslmed.aaf1090","article-title":"Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification","volume":"8","author":"Dey","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.stemcr.2018.10.007_bib14","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.bmcl.2013.03.113","volume":"23","author":"Engers","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.stemcr.2018.10.007_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00264-010-0959-y","article-title":"Treatment of articular cartilage lesions of the knee","volume":"34","author":"Falah","year":"2010","journal-title":"Int. Orthop."},{"key":"10.1016\/j.stemcr.2018.10.007_bib16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bbrc.2008.10.093","article-title":"A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor","volume":"377","author":"Fukuda","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.stemcr.2018.10.007_bib17","doi-asserted-by":"crossref","first-page":"e112291","DOI":"10.1371\/journal.pone.0112291","article-title":"Derivation of mesenchymal stromal cells from pluripotent stem cells through a neural crest lineage using small molecule compounds with defined media","volume":"9","author":"Fukuta","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.stemcr.2018.10.007_bib18","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1242\/dev.126.11.2551","article-title":"The type I serine\/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo","volume":"126","author":"Gu","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.stemcr.2018.10.007_bib19","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/stem.1221","article-title":"Pathogenic mutation of ALK2 inhibits induced pluripotent stem cell reprogramming and maintenance: mechanisms of reprogramming and strategy for drug identification","volume":"30","author":"Hamasaki","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.stemcr.2018.10.007_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/cb9002865","article-title":"In\u00a0vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors","volume":"5","author":"Hao","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.stemcr.2018.10.007_bib21","doi-asserted-by":"crossref","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.stemcr.2018.10.007_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbrc.2013.01.003","article-title":"Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells","volume":"432","author":"Hayakawa","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.stemcr.2018.10.007_bib23","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1021\/jm060434q","article-title":"N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src\/Abl kinase inhibitor","volume":"49","author":"Hennequin","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.stemcr.2018.10.007_bib24","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI93521","article-title":"Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva","volume":"127","author":"Hino","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.stemcr.2018.10.007_bib25","doi-asserted-by":"crossref","first-page":"15438","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","volume":"112","author":"Hino","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.stemcr.2018.10.007_bib26","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1101\/gad.10.13.1580","article-title":"Bone morphogenetic proteins: multifunctional regulators of vertebrate development","volume":"10","author":"Hogan","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.stemcr.2018.10.007_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/BMM:3:3-4:183","article-title":"The phenotype of fibrodysplasia ossificans progressiva","volume":"3","author":"Kaplan","year":"2005","journal-title":"Clin. Rev. Bone Miner. Metab."},{"key":"10.1016\/j.stemcr.2018.10.007_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1196\/annals.1402.039","article-title":"Morphogen receptor genes and metamorphogenes: skeleton keys to metamorphosis","volume":"1116","author":"Kaplan","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.stemcr.2018.10.007_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.berh.2007.11.007","article-title":"Fibrodysplasia ossificans progressiva","volume":"22","author":"Kaplan","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.stemcr.2018.10.007_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1242\/dmm.010280","article-title":"Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis","volume":"5","author":"Kaplan","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.stemcr.2018.10.007_bib31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/gt.2011.152","article-title":"Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting","volume":"19","author":"Kaplan","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.stemcr.2018.10.007_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1750-1172-8-163","article-title":"Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trial","volume":"8","author":"Kitoh","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.stemcr.2018.10.007_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41467-018-02872-2","article-title":"Activin-dependent signaling in fibro\/adipogenic progenitors causes fibrodysplasia ossificans progressiva","volume":"9","author":"Lees-Shepard","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stemcr.2018.10.007_bib34","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.bbagrm.2013.08.002","article-title":"Serum regulation of Id1 expression by a BMP pathway and BMP responsive element","volume":"1829","author":"Lewis","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.stemcr.2018.10.007_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6065\/apem.2017.22.1.1","article-title":"Bone modeling, remodeling, and skeletal health in children and adolescents: mineral accrual, assessment and treatment","volume":"22","author":"Maggioli","year":"2017","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.stemcr.2018.10.007_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)00121-5","article-title":"TGFbeta signaling in growth control, cancer, and heritable disorders","volume":"103","author":"Massague","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.stemcr.2018.10.007_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1750-1172-8-190","article-title":"Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation","volume":"8","author":"Matsumoto","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.stemcr.2018.10.007_bib38","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/stem.1981","article-title":"New protocol to optimize iPS cells for genome analysis of fibrodysplasia ossificans progressiva","volume":"33","author":"Matsumoto","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.stemcr.2018.10.007_bib39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/dbio.1999.9378","article-title":"Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis","volume":"213","author":"Mishina","year":"1999","journal-title":"Dev. Biol."},{"key":"10.1016\/j.stemcr.2018.10.007_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jb\/mvp148","article-title":"Bone morphogenetic protein receptors and signal transduction","volume":"147","author":"Miyazono","year":"2010","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.stemcr.2018.10.007_bib41","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1038\/sj.onc.1210478","article-title":"Targeting the function of the HER2 oncogene in human cancer therapeutics","volume":"26","author":"Moasser","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.stemcr.2018.10.007_bib42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2017.111","article-title":"Opportunities and challenges in phenotypic drug discovery: an industry perspective","volume":"16","author":"Moffat","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.stemcr.2018.10.007_bib43","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/cb300655w","article-title":"Development of an ALK2-biased BMP type I receptor kinase inhibitor","volume":"8","author":"Mohedas","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.stemcr.2018.10.007_bib44","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.febslet.2012.02.043","article-title":"Promiscuity and specificity in BMP receptor activation","volume":"586","author":"Mueller","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.stemcr.2018.10.007_bib45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1442-2042.2006.01342.x","article-title":"Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in\u00a0vitro and in\u00a0vivo","volume":"13","author":"Nagasawa","year":"2006","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.stemcr.2018.10.007_bib46","doi-asserted-by":"crossref","DOI":"10.1242\/dev.165431","article-title":"Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cells","volume":"145","author":"Nakajima","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.stemcr.2018.10.007_bib47","doi-asserted-by":"crossref","first-page":"e53771","DOI":"10.1371\/journal.pone.0053771","article-title":"Genetically matched human iPS cells reveal that propensity for cartilage and bone differentiation differs with clones, not cell type of origin","volume":"8","author":"Nasu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.stemcr.2018.10.007_bib48","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2014.01.005","article-title":"Premature termination of reprogramming in\u00a0vivo leads to cancer development through altered epigenetic regulation","volume":"156","author":"Ohnishi","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.stemcr.2018.10.007_bib49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bone.2016.06.014","article-title":"Targeted stimulation of retinoic acid receptor-gamma mitigates the formation of heterotopic ossification in an established blast-related traumatic injury model","volume":"90","author":"Pavey","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.stemcr.2018.10.007_bib50","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1096\/fasebj.13.15.2105","article-title":"Specificity, diversity, and regulation in TGF-beta superfamily signaling","volume":"13","author":"Piek","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.stemcr.2018.10.007_bib51","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbmr.2728","article-title":"The natural history of flare-ups in fibrodysplasia ossificans progressiva (FOP): a comprehensive global assessment","volume":"31","author":"Pignolo","year":"2016","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.stemcr.2018.10.007_bib52","doi-asserted-by":"crossref","first-page":"e62721","DOI":"10.1371\/journal.pone.0062721","article-title":"A new class of small molecule inhibitor of BMP signaling","volume":"8","author":"Sanvitale","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.stemcr.2018.10.007_bib53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nm.2334","article-title":"Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-gamma agonists","volume":"17","author":"Shimono","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.stemcr.2018.10.007_bib54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1385\/BMM:3:3-4:201","article-title":"The genetics of fibrodysplasia ossificans progressiva","volume":"3","author":"Shore","year":"2005","journal-title":"Clin. Rev. Bone Miner. Metab."},{"key":"10.1016\/j.stemcr.2018.10.007_bib55","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrrheum.2010.122","article-title":"Inherited human diseases of heterotopic bone formation","volume":"6","author":"Shore","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.stemcr.2018.10.007_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.stemcr.2018.10.007_bib57","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1359\/jbmr.1997.12.8.1174","article-title":"Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in\u00a0vitro","volume":"12","author":"Shukunami","year":"1997","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.stemcr.2018.10.007_bib58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bone.2016.02.008","article-title":"Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent","volume":"90","author":"Sinha","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.stemcr.2018.10.007_bib59","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/gt.2011.193","article-title":"Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva","volume":"19","author":"Takahashi","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.stemcr.2018.10.007_bib60","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/srep00455","article-title":"Human chondrogenic paraxial mesoderm, directed specification and prospective isolation from pluripotent stem cells","volume":"2","author":"Umeda","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.stemcr.2018.10.007_bib61","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.150.3698.893","article-title":"Bone: formation by autoinduction","volume":"150","author":"Urist","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.stemcr.2018.10.007_bib62","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/jbmr.2848","article-title":"Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling","volume":"31","author":"Wang","year":"2016","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.stemcr.2018.10.007_bib63","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07863","article-title":"piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells","volume":"458","author":"Woltjen","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2018.10.007_bib64","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.3201241","article-title":"Novel regulators of bone formation: molecular clones and activities","volume":"242","author":"Wozney","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.stemcr.2018.10.007_bib65","first-page":"600","article-title":"EWS\/ATF1 expression induces sarcomas from neural crest-derived cells in mice","volume":"123","author":"Yamada","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.stemcr.2018.10.007_bib66","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm.1888","article-title":"BMP type I receptor inhibition reduces heterotopic [corrected] ossification","volume":"14","author":"Yu","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.stemcr.2018.10.007_bib67","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1172\/JCI34174","article-title":"Regulation of chondrogenesis and chondrocyte differentiation by stress","volume":"118","author":"Zuscik","year":"2008","journal-title":"J.\u00a0Clin. Invest."}],"container-title":["Stem Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671118304302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671118304302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:39:54Z","timestamp":1761989994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213671118304302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S2213671118304302"],"URL":"https:\/\/doi.org\/10.1016\/j.stemcr.2018.10.007","relation":{},"ISSN":["2213-6711"],"issn-type":[{"value":"2213-6711","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An mTOR Signaling Modulator Suppressed Heterotopic Ossification of\u00a0Fibrodysplasia Ossificans Progressiva","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stemcr.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors.","name":"copyright","label":"Copyright"}]}}